In APP/PS1 transgenic AD mice, intravenous administration of quercetin nanoparticles at doses of 10 to 30 mg/kg for 30 days led to improvements in memory as assessed by the Morris water maze and NOR tasks (Sun et al., 2016[63]). This evidence concerns the gene APP and Alzheimer disease.